BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 38679197)

  • 1. Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital.
    Perrier Q; Minoves M; Cerana S; Reymond F; Ducki C; Decaens T; Lehmann A; Bedouch P
    Eur J Hosp Pharm; 2023 May; ():. PubMed ID: 37248032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug cost savings in phase III hematological oncology clinical trials in a university hospital.
    Herledan C; Ranchon F; Schwiertz V; Baudouin A; Karlin L; Ghesquières H; Salles G; Rioufol C
    Hematol Oncol; 2020 Oct; 38(4):576-583. PubMed ID: 32469095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials and drug cost savings for Italian health service.
    D'Ambrosio F; De Feo G; Botti G; Capasso A; Pignata S; Maiolino P; Triassi M; Nardone A; Perrone F; Piezzo M; Grimaldi AM; Palazzo I; De Stasio I; D'Aniello R; Morabito A; Pascarella G
    BMC Health Serv Res; 2020 Nov; 20(1):1089. PubMed ID: 33243262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010).
    Liniker E; Harrison M; Weaver JM; Agrawal N; Chhabra A; Kingshott V; Bailey S; Eisen TG; Corrie PG
    Br J Cancer; 2013 Oct; 109(8):2051-7. PubMed ID: 24064969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure.
    Gasperoni L; Cafaro A; Ferretti E; Di Iorio V; Nanni O; Masini C
    Eur J Hosp Pharm; 2023 Mar; 30(2):96-100. PubMed ID: 35577545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.
    Gómez Mediavilla B; Lanza León P; Martínez Callejo V; Cantarero Prieto D; Lanza Postigo M; Salcedo Lambea M; Blanco Mesonero Y; Ochagavia Sufrategui M; Durán I; Sarabia Cobo CM
    Biomed J; 2024 Apr; ():100742. PubMed ID: 38679197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
    Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis.
    Whiting P; Al M; Westwood M; Ramos IC; Ryder S; Armstrong N; Misso K; Ross J; Severens J; Kleijnen J
    Health Technol Assess; 2015 Jul; 19(58):1-228, v-vi. PubMed ID: 26215747
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.